Guozheng Ding

Anqing, 246000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Peripheral blood eosinophil count for predicting progression-free survival in non-small cell lung cancer: A retrospective cohort study.

Peripheral blood eosinophil count for predicting progression-free survival in non-small cell lung cancer: A retrospective cohort study.

Journal: Medicine

Published: September 27, 2025

Angelica Dahurica extracts improve the radiosensitivity of non-small-cell lung cancer cells via deactivating the JAK1/STAT3 axis.

Angelica Dahurica extracts improve the radiosensitivity of non-small-cell lung cancer cells via deactivating the JAK1/STAT3 axis.

Journal: American journal of translational research

Published: September 25, 2025

Development of a machine learning model for preoperative prediction of spread through air spaces in resectable non-small cell lung cancer: A single-center retrospective study.

Development of a machine learning model for preoperative prediction of spread through air spaces in resectable non-small cell lung cancer: A single-center retrospective study.

Journal: Oncology letters

Published: September 11, 2025

Inverse association between serum sLRP-1 levels and obstructive sleep apnea in snoring individuals: a case-control study based on polysomnography and machine learning models.

Inverse association between serum sLRP-1 levels and obstructive sleep apnea in snoring individuals: a case-control study based on polysomnography and machine learning models.

Journal: Sleep & breathing = Schlaf & Atmung

Published: July 03, 2025

Evaluating the Efficacy of Capreomycin and Levofloxacin Combination Therapy in Multidrug-Resistant Tuberculosis Patients.

Evaluating the Efficacy of Capreomycin and Levofloxacin Combination Therapy in Multidrug-Resistant Tuberculosis Patients.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: November 06, 2024

Excellent response of lung adenocarcinoma harboring a rare SLC8A1 downstream intergenic region ALK fusion to ceritinib treatment: A case report.

Excellent response of lung adenocarcinoma harboring a rare SLC8A1 downstream intergenic region ALK fusion to ceritinib treatment: A case report.

Journal: Medicine

Published: August 31, 2022

Predictive value of microvascular density for response to anlotinib in advanced NSCLC.

Predictive value of microvascular density for response to anlotinib in advanced NSCLC.

Journal: Medicine

Published: August 28, 2021

The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China.

The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China.

Journal: OncoTargets and therapy

Published: November 02, 2016

Comparison of outcomes of tyrosine kinase inhibitor in first- or second-line therapy for advanced non-small-cell lung cancer patients with sensitive EGFR mutations.

Comparison of outcomes of tyrosine kinase inhibitor in first- or second-line therapy for advanced non-small-cell lung cancer patients with sensitive EGFR mutations.

Journal: Oncotarget

Published: June 17, 2016

Showing 1-9 of 9

Last Updated: 09/26/2026